Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
10.1016/j.mcna.2023.06.001 34 LangerR
Obesity care, GLP-1s and the new equation for plan sponsors GLP-1s are transforming obesity care, and the decisions plan sponsors make will impact their organizations for years to come Daniel Cusator , MD, MBA, Account Medical Director, Blue Cross Blue Shield of Tennessee Shane Lipp , Senior Benefits Manager, Synovus Claire Morrow , PT, DPT, OCS, FAAOMPT, Physical Therapy Consultant Senior Manager, Hinge Health Charlie Smith , MD, Chief Medical Officer, AON Gabrielle Boisvert , Head of Solution Strategy, Teladoc Health (Moderator) In 2021, it was the beginning of the widespread, mainstream use of GLP-1s for weight loss
A thorough medical evaluation, including blood work to check IGF-1 levels and overall hormone status, is the safest first step before starting therapy
(2021) GLP-1 receptor agonists: an updated review of head-to-head clinical studies and patients persistence of treatment based on estimations by Uzoigwe et al
Morning vs Evening: The Real Difference The biggest difference is not the clock
US$ 27.98
US$ 21.88
US$ 20.64
US$ 29.19
US$ 21.42
US$ 29.14
US$ 26.87
US$ 21.08
US$ 27.72
US$ 28.42
